Resolving when and where C3ar1 is needed are questions of significant translational importance because, as a G-protein-coupled receptor, human C3AR1 serves as a potential therapeutic target for disorders associated with complement upregulation, such as schizophrenia. This evidence concerns the gene C3AR1 and schizophrenia.